Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials per carton (NDC 0409-4699-30); b) 1 g/100 mL, 10 Units x 100 mL Single patient infusion vials per carton (NDC 0409-4699-24); Rx only, Hospira, Inc., Lake Forest, IL 60045, USA.
Published June 20, 2012 · Recall initiated: April 11, 2012
Summary
FDA records drug Class II recall D-1382-2012, published June 20, 2012 and initiated April 11, 2012. Recalling firm: Hospira, Inc.; Status: Terminated; Reported quantity: a) 36,125 vials; b) 31,280 vials; Lot: Lot #: a) 03440DJ*, Exp 1MAR2013; b) 07947DJ, Exp 1JUL2013; 10134DJ, Exp 1OCT2013; Note: * the lot may be followed by 01. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel
What to do
Voluntary: Firm initiated · Letter
Get an email if PROPOFOL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PROPOFOL
- Manufacturer
- Hospira, Inc.
- Distributor
- Nationwide.
- Lot
- Lot #: a) 03440DJ*, Exp 1MAR2013; b) 07947DJ, Exp 1JUL2013; 10134DJ, Exp 1OCT2013; Note: * the lot may be followed by 01.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54)September 21, 2022
- FDAPropofol Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL per glass fliptop vial (NDCAugust 3, 2022
- FDAPropofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials, packaged in 5February 25, 2015
- FDAPropofol Injectable Emulsion, 1%, 200 mg/20 mL, (10mg/mL), 20 mL, Single patient infusion vial, ContainsFebruary 4, 2015
- FDAEndocet (oxycodone and acetaminophen) tablets, USP, 10 mg/650 mg, 100-count tablets per bottle, Rx only,June 20, 2012
- FDAAlsoSalt Sodium Free Butter flavored Salt Substitute, 2.5 oz. bottleJune 20, 2012
Questions about this recall
Was Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials per carton (NDC 0409-4699-30); b) 1 g/100 mL, 10 Units x 100 mL Single patient infusion vials per carton (NDC 0409-4699-24); Rx only, Hospira, Inc., Lake Forest, IL 60045, USA. recalled?
Yes. FDA published recall D-1382-2012 on June 20, 2012. Reported hazard: Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PROPOFOL.